SCN5A and ventricular tachycardia: Some pathogenic SCN5A variants causing Brugada syndrome were recently associated to a markedly increase in the risk of ventricular tachycardia or ventricular fibrillation22,23 and it has been reported that topiramate may reveal or worsen Brugada syndrome.24